(5-Benzoyl-2-methyl-4-{[1-(pyridin-4-yl)1H-1,2,3-triazol-4-yl]methoxy}-1-benzofuran-7-yl)(phenyl) methanone

被引：0
|
作者：
Zhang, Xiao-Qin [1 ]
Zhang, Hai-Liang [2 ]
Dong, Zhu-Yong [2 ]
Qian, Qiang [2 ]
Wang, Yu-Guang [1 ]
机构：
[1] Zhejiang Univ Technol, Coll Biol & Environm Engn, Hangzhou 310014, Zhejiang, Peoples R China
[2] Zhejiang SiXian Pharmaceut Co Ltd, Shaoxing 312065, Peoples R China
来源：
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS | 2012年 / 68卷
关键词：
D O I：
10.1107/S1600536812023720
中图分类号：
O7 [晶体学];
学科分类号：
0702 ; 070205 ; 0703 ; 080501 ;
摘要：
The crystal structure of the title compound, C31H22N4O4, features weak C-H center dot center dot center dot O interactions. The dihedral angle between the fused benzene and furan rings is 2.49 (15)degrees, while that between the triazole and pyridine rings is 10.23(18) degrees
引用
收藏
页码：O1916 / +
页数：9
相关论文
共 50 条
  • [1] Di-tert-butyl N-{[1-(pyridin-4-yl)-1H-1,2,3-triazol-4-yl] methyl}iminodiacetate
    Francois, Alison
    Marty, Louise
    Picard, Claude
    Mallet-Ladeira, Sonia
    Benoist, Eric
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O3162 - +
  • [2] 2-Bromo-3-((1-(7-chloroquinolin-4-yl)-1H-1,2,3-triazol-4-yl)-methoxy)-benzaldehyde
    Yun, Xiaoyun
    Xie, Yuhan
    Ng, Jerome P. L.
    Law, Betty Yuen Kwan
    Wong, Vincent Kam Wai
    Coghi, Paolo
    MOLBANK, 2022, 2022 (01)
  • [3] {5-Methyl-1-[8-(trifluoromethyl)quinolin-4-yl]-1H-1,2,3-triazol-4-yl}( morpholino)-methanone
    Anuradha, N.
    Thiruvalluvar, A.
    Mahalinga, M.
    Butcher, R. J.
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2008, 64 : O2375 - U2693
  • [4] 1-[5-Methyl-1-(4-nitrophenyl)-1H-1,2,3-triazol-4-yl]ethanone
    Vinutha, N.
    Kumar, S. Madan
    Nithinchandrab
    Balakrishna, Kalluraya
    Lokanath, N. K.
    Revannasiddaiah, D.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O1724 - +
  • [5] 1-{5-Methyl-1-[8-(trifluoromethyl)-quinolin-4-yl]-1H-1,2,3-triazol-4-yl}-ethanone
    Thiruvalluvar, A.
    Subramanyam, M.
    Butcher, R. J.
    Mahalinga, M.
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2007, 63 : O4813 - U6034
  • [6] 1-{1-[(2-Chlorothiazol-5-yl)methyl]-5-methyl-1H-1,2,3-triazol-4-yl}ethanone
    Chen, Xiao-Bao
    Tian, Jia-Hua
    Xu, Jing
    Yu, Yong
    Wang, Qun
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2009, 65 : O2840 - U1645
  • [7] N,N-Dibenzyl-1-(1-[(4-methyl-2-phenyl-4,5-dihydrooxazol-4-yl)methyl)]-1H-1,2,3-triazol-4-yl)methanamine
    Younas, Aouine
    Abdelilah, El Hallaoui
    Anouar, Alami
    MOLBANK, 2014, (01)
  • [8] (E)-N-(1,3-Benzodioxol-5-yl)-1-(4-{[1(prop-2-en-1-yl)-1H-1,2,3-triazol-4-yl]methoxy}phenyl)methanimine
    Akkurt, Mehmet
    Jarrahpour, Aliasghar
    Chermahini, Mehdi Mohammadi
    Shiri, Pezhman
    Buyukgungor, Orhan
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O1576 - +
  • [9] Design, synthesis and anticancer activity of 5-((2-(4-bromo/chloro benzoyl) benzofuran-5-yl) methyl)-2-((1-(substituted)-1H-1,2,3-triazol-4-yl)methoxy)benzaldehyde analogues
    T. Vishnu
    M. Veerabhadraiah
    V. Krishna Chaitanya
    M. Nagamani
    M. Raghavender
    P. Jalapathi
    Molecular Diversity, 2023, 27 : 2695 - 2713
  • [10] Design, synthesis and anticancer activity of 5-((2-(4-bromo/chloro benzoyl) benzofuran-5-yl) methyl)-2-((1-(substituted)-1H-1,2,3-triazol-4-yl)methoxy) benzaldehyde analogues
    Vishnu, T.
    Veerabhadraiah, M.
    Chaitanya, V. Krishna
    Nagamani, M.
    Raghavender, M.
    Jalapathi, P.
    MOLECULAR DIVERSITY, 2023, 27 (06) : 2695 - 2713
12345